Personalized Genomics Market Growth Accelerated by Rapid Adoption of Genetic Testing
Personalized Genomics Market |
Personalized genomics involves genetic testing to understand specific genes and DNA variations associated with an individual's health and disease risks. Genetic testing enables early detection of genetic conditions and diseases, thereby improving patient outcomes. It aids in identifying customized drug prescriptions and treatment plans suitable for the individual's genetic make-up.
The global
Personalized Genomics Market is estimated to be valued at US$ 9.14 Bn in 2024
and is expected to exhibit a CAGR of 0.0% over the forecast period 2024 to
2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rapid adoption of genetic
testing has accelerated market growth for personalized genomics. Genetic
testing has gained immense popularity in recent years due to increasing
awareness about its benefits. It enables people to understand their risks of
developing certain diseases based on their DNA makeup and take preventive
measures accordingly. This is driving more individuals to opt for genetic
testing and fueling the growth of the personalized genomics market.
Segment
Analysis
The global Personalized Genomics Market is segmented into direct-to-consumer testing
and professional testing. The direct-to-consumer testing segment currently
dominates the market as these tests enable individuals to receive genetic risk
assessments directly without involving a healthcare professional. The ease of
use and lower costs associated with direct-to-consumer tests are driving their
higher adoption.
Key Takeaways
Global
Personalized Genomics Market Demand is expected to witness high growth.
Regional analysis: The North America region is
currently the fastest growing market for personalized genomics due to favorable
government initiatives and increasing investments in genome sequencing
research.
Comments
Post a Comment